We are live on ! Find out more
PCM

Perkins Capital Management Portfolio holdings

AUM $133M
1-Year Est. Return 127.86%
This Fund
S&P 500
This Quarter Est. Return
-1.51%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$106M
AUM Growth
-$13.8M
Cap. Flow
-$2.56M
Cap. Flow %
-2.41%
Top 10 Hldgs %
44.3%
Holding
92
New
2
Increased
11
Reduced
51
Closed
4

Top Buys

Rank Stock Value
1
BDSX icon
Biodesix
BDSX
+$592K
2
MRNA icon
Moderna
MRNA
+$465K
3
PSNL icon
Personalis
PSNL
+$353K
4
MGNI icon
Magnite
MGNI
+$227K
5
MDXH icon
MDxHealth
MDXH
+$60.8K

Top Sells

Rank Stock Value
1
FPAY
FlexShopper
FPAY
+$552K
2
AKTS
Akoustis Technologies Inc
AKTS
+$464K
3
VCYT icon
Veracyte
VCYT
+$361K
4
REKR icon
Rekor Systems
REKR
+$344K
5
MDT icon
Medtronic
MDT
+$294K

Sector Composition

Rank Sector Weight
1 Healthcare 58.09%
2 Technology 26.18%
3 Communication Services 5.31%
4 Consumer Staples 4.28%
5 Industrials 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.05T
$11.4M 10.77%
12,622
-15
-0.1% -$12K
MSFT icon
2
Microsoft
MSFT
$3.81T
$6.51M 6.14%
14,576
-550
-4% -$232K
NTRA icon
3
Natera
NTRA
$47B
$6.23M 5.87%
57,550
-2,575
-4% -$262K
IDXX icon
4
Idexx Laboratories
IDXX
$43.7B
$5.12M 4.82%
10,500
– –
ELUT icon
5
Elutia
ELUT
$39M
$3.87M 3.65%
780,102
-17,500
-2% -$56.9K
AMD icon
6
Advanced Micro Devices
AMD
$760B
$3.66M 3.45%
22,554
– –
LMAT icon
7
LeMaitre Vascular
LMAT
$1.84B
$2.81M 2.65%
34,201
-1,100
-3% -$80.8K
NEO icon
8
NeoGenomics
NEO
$2.32B
$2.6M 2.45%
187,300
-5,900
-3% -$83.6K
ABT icon
9
Abbott
ABT
$195B
$2.58M 2.44%
24,880
-500
-2% -$53K
AIRG icon
10
Airgain
AIRG
$67.6M
$2.21M 2.08%
365,150
-10,000
-3% -$54.7K
VCYT icon
11
Veracyte
VCYT
$3.48B
$2.14M 2.02%
98,830
-17,150
-15% -$361K
AXGN icon
12
Axogen
AXGN
$2.77B
$2.1M 1.97%
289,349
-8,600
-3% -$58.8K
QUIK icon
13
QuickLogic
QUIK
$198M
$2.09M 1.97%
201,106
-5,500
-3% -$69.4K
MGNI icon
14
Magnite
MGNI
$3.4B
$1.98M 1.87%
149,075
+20,750
+16% +$227K
ATEC icon
15
Alphatec Holdings
ATEC
$1.46B
$1.89M 1.78%
180,567
-3,700
-2% -$43.1K
INUV icon
16
Inuvo
INUV
$11.5M
$1.77M 1.67%
690,365
-11,981
-2% -$36.5K
CTLP
17
DELISTED
Cantaloupe
CTLP
$1.61M 1.52%
244,600
-11,500
-4% -$74.6K
DGII icon
18
Digi International
DGII
$2.88B
$1.61M 1.52%
70,208
-1,625
-2% -$43.6K
USIO icon
19
Usio Inc
USIO
$78.9M
$1.56M 1.47%
1,022,193
-20,500
-2% -$31.6K
OOMA icon
20
Ooma
OOMA
$629M
$1.54M 1.45%
154,800
-1,750
-1% -$13.9K
MRK icon
21
Merck
MRK
$366B
$1.48M 1.39%
11,925
-300
-2% -$38.6K
VCEL icon
22
Vericel Corp
VCEL
$2.1B
$1.43M 1.35%
31,250
– –
ABBV icon
23
AbbVie
ABBV
$451B
$1.37M 1.29%
7,983
-525
-6% -$87K
PFIE
24
DELISTED
Profire Energy, Inc
PFIE
$1.29M 1.21%
907,420
-38,100
-4% -$61.5K
GIS icon
25
General Mills
GIS
$22.2B
$1.29M 1.21%
20,325
+50
+0.2% +$3.43K
1
2 3 4

Similar funds

AA
Alpha Advisors Richmond, Virginia $133M AUM 20.23% 1-Year Est. Return
WA
Winter & Associates St. Paul, Minnesota $133M AUM
AC
Aldebaran Capital Carmel, Indiana $133M AUM 42.18% 1-Year Est. Return
BCVI
Bain Capital Venture Investors Boston, Massachusetts $133M AUM 50.19% 1-Year Est. Return
SWM
Sherman Wealth Management Gaithersburg, Maryland $133M AUM
HAP
Harbor Asset Planning Belmont, Massachusetts $133M AUM 24.86% 1-Year Est. Return
RHIG
R.H. Investment Group Scottsdale, Arizona $133M AUM 23.61% 1-Year Est. Return
CWM
Capstone Wealth Management Billings, Montana $133M AUM

Perkins Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Perkins Capital Management held 92 positions worth $106M, down 11% from $120M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Perkins Capital Management's Q2 2024 filing shows 2 new, 11 increased, 51 reduced and 4 closed positions. Its largest new stake was Biodesix: 20,739 shares worth $635K. The largest sale was FlexShopper, an estimated $552K.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, up from 51% a quarter earlier, followed by Technology and Communication Services.

  • Perkins Capital Management's largest Q2 2024 buy was Biodesix: 20,739 shares worth $635K.
  • Perkins Capital Management added most to Moderna in Q2 2024, an estimated $465K increase.
  • Perkins Capital Management's biggest Q2 2024 reduction was FlexShopper, cutting an estimated $552K.
  • Perkins Capital Management fully exited Rekor Systems in Q2 2024, selling an estimated $344K.
  • Perkins Capital Management's ten largest holdings make up 44% of its $106M portfolio in Q2 2024.
  • Perkins Capital Management opened 2 new positions and closed 4 in Q2 2024.
  • Perkins Capital Management's portfolio value fell 11% quarter-over-quarter to $106M.

Based on Perkins Capital Management's 13F filing for Q2 2024, filed 9 Aug 2024.